Skip to main content
Erschienen in: Journal of Neurology 6/2017

31.03.2017 | Letter to the Editors

Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report

verfasst von: E. M. Rodenburg, F. H. Vermeij, M. J. van den Bent, J. M. Zuetenhorst

Erschienen in: Journal of Neurology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sirs, …
Literatur
1.
Zurück zum Zitat Cohen JI, Brunell PA, Straus SE, Krause PR (1999) Recent advances in varicella-zoster virus infection. Ann Intern Med 130(11):922–932CrossRefPubMed Cohen JI, Brunell PA, Straus SE, Krause PR (1999) Recent advances in varicella-zoster virus infection. Ann Intern Med 130(11):922–932CrossRefPubMed
2.
Zurück zum Zitat Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD (1992) Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166(5):1153–1156CrossRefPubMed Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD (1992) Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166(5):1153–1156CrossRefPubMed
3.
Zurück zum Zitat Hata A, Kuniyoshi M, Ohkusa Y (2011) Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 39(6):537–544CrossRefPubMedPubMedCentral Hata A, Kuniyoshi M, Ohkusa Y (2011) Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 39(6):537–544CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645CrossRefPubMed Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645CrossRefPubMed
5.
Zurück zum Zitat Rusthoven JJ, Ahlgren P, Elhakim T, Pinfold P, Reid J, Stewart L, Feld R (1988) Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 148(7):1561–1566CrossRefPubMed Rusthoven JJ, Ahlgren P, Elhakim T, Pinfold P, Reid J, Stewart L, Feld R (1988) Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 148(7):1561–1566CrossRefPubMed
6.
Zurück zum Zitat Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL et al (2012) The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomark Prev 22(1):82–90CrossRef Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL et al (2012) The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomark Prev 22(1):82–90CrossRef
7.
Zurück zum Zitat Calabria F, Zappini F, Vattemi G, Tinazzi M (2014) Pearls & Oy-sters: an unusual case of varicella-zoster virus cerebellitis and vasculopathy. Neurology 82(2):e14–e15CrossRefPubMed Calabria F, Zappini F, Vattemi G, Tinazzi M (2014) Pearls & Oy-sters: an unusual case of varicella-zoster virus cerebellitis and vasculopathy. Neurology 82(2):e14–e15CrossRefPubMed
8.
Zurück zum Zitat Mpaka M, Karantanas AH, Zakynthinos E (2008) Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung 37(1):61–66CrossRefPubMed Mpaka M, Karantanas AH, Zakynthinos E (2008) Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung 37(1):61–66CrossRefPubMed
9.
Zurück zum Zitat De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP (2011) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18(8):808–819CrossRefPubMed De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP (2011) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18(8):808–819CrossRefPubMed
10.
Zurück zum Zitat Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2013) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93(3):479–484CrossRefPubMed Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2013) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93(3):479–484CrossRefPubMed
11.
Zurück zum Zitat Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33(10):786–788CrossRefPubMed Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33(10):786–788CrossRefPubMed
12.
Zurück zum Zitat Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17(7):e529–e534CrossRefPubMed Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17(7):e529–e534CrossRefPubMed
13.
Zurück zum Zitat Masci G, Magagnoli M, Gullo G, Morenghi E, Garassino I, Simonelli M, Santoro A (2006) Herpes infections in breast cancer patients treated with adjuvant chemotherapy. Oncology 71(3–4):164–167PubMed Masci G, Magagnoli M, Gullo G, Morenghi E, Garassino I, Simonelli M, Santoro A (2006) Herpes infections in breast cancer patients treated with adjuvant chemotherapy. Oncology 71(3–4):164–167PubMed
14.
Zurück zum Zitat König J, Müller F, Fromm MF (2013) Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65(3):944–966CrossRefPubMed König J, Müller F, Fromm MF (2013) Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65(3):944–966CrossRefPubMed
15.
Zurück zum Zitat Lee CA, O’Connor MA, Ritchie TK, Galetin A, Cook JA, Ragueneau-Majlessi I et al (2015) Breast Cancer Resistance Protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug–drug interaction study design. Drug Metab Dispos 43:490–509CrossRefPubMed Lee CA, O’Connor MA, Ritchie TK, Galetin A, Cook JA, Ragueneau-Majlessi I et al (2015) Breast Cancer Resistance Protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug–drug interaction study design. Drug Metab Dispos 43:490–509CrossRefPubMed
Metadaten
Titel
Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report
verfasst von
E. M. Rodenburg
F. H. Vermeij
M. J. van den Bent
J. M. Zuetenhorst
Publikationsdatum
31.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8466-3

Weitere Artikel der Ausgabe 6/2017

Journal of Neurology 6/2017 Zur Ausgabe

Neurological Update

Neuroborreliosis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.